Skip to main content

Orbis Allan Gray Ltd

SEC CIK
0001663865
Latest filing
Aug 14, 2026

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by Orbis Allan Gray Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overviewAll 13F holders of DYNFull Q2 2026 holdings

Shares (Q2 2026)
7,006,542
Value
$155.6M
% of portfolio
0.5%
Quarters held
3
Since Q4 2025
Holdings of DYN by Orbis Allan Gray Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,006,542$155.6M0.5%+244,311+3.6%AddedHolders
Q1 20266,762,231$122.6M0.5%+1,960,303+40.8%AddedHolders
Q4 20254,801,928$93.9M0.4%+4,801,928NewHolders